CD99 is commonly overexpressed in some tumor types, particularly in Ewing sarcoma, acute leukemias/myelodysplastic syndromes, and malignant gliomas, and more sporadically in other tumors, while it can be downregulated in other neoplasms [13]. This evidence concerns the gene CD99 and neoplasm.